Medicenna Therapeutics Corp. (MDNA.TO)

CAD 1.75

(-2.23%)

Gross Profit Summary of Medicenna Therapeutics Corp.

  • Medicenna Therapeutics Corp.'s latest annual gross profit in 2023 was -5000.00 CAD , down 0.0% from previous year.
  • Medicenna Therapeutics Corp.'s latest quarterly gross profit in 2024 Q1 was - CAD , up 600.0% from previous quarter.
  • Medicenna Therapeutics Corp. reported a annual gross profit of -5000.00 CAD in annual gross profit 2022, up 86.84% from previous year.
  • Medicenna Therapeutics Corp. reported a annual gross profit of -38 Thousand CAD in annual gross profit 2021, up 5.0% from previous year.
  • Medicenna Therapeutics Corp. reported a quarterly gross profit of -5000.00 CAD for 2023 FY, down 0.0% from previous quarter.
  • Medicenna Therapeutics Corp. reported a quarterly gross profit of -2000.00 CAD for 2023 Q3, down -100.0% from previous quarter.

Annual Gross Profit Chart of Medicenna Therapeutics Corp. (2023 - 2013)

Historical Annual Gross Profit of Medicenna Therapeutics Corp. (2023 - 2013)

Year Gross Profit Gross Profit Growth
2023 -5000.00 CAD 0.0%
2022 -5000.00 CAD 86.84%
2021 -38 Thousand CAD 5.0%
2020 -40 Thousand CAD -406.78%
2019 -7893.00 CAD -15.77%
2018 -6818.00 CAD 29.74%
2017 -9704.00 CAD -49.59%
2016 -6487.00 CAD -352.06%
2015 -1435.00 CAD 0.0%
2014 - CAD 0.0%
2013 - CAD 0.0%

Peer Gross Profit Comparison of Medicenna Therapeutics Corp.

Name Gross Profit Gross Profit Difference
Appili Therapeutics Inc. 813.74 Thousand CAD 100.614%
Eupraxia Pharmaceuticals Inc. -209.91 Thousand CAD 97.618%
Helix BioPharma Corp. -14 Thousand CAD 64.286%
Microbix Biosystems Inc. 7.48 Million CAD 100.067%
Satellos Bioscience Inc. -8.81 Million CAD 99.943%
Oncolytics Biotech Inc. -403 Thousand CAD 98.759%
Sernova Corp. -445.55 Thousand CAD 98.878%